SCHEMBL29567131

SCHEMBL29567131

Cc1cccc(C)c1-c1cc(O)nc(NS(=O)(=O)c2cnn(C)c2)n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CG P48736 2/20 0.38
▸ PIK3CD O00329 1/20 0.38
▸ PIK3CB P42338 1/20 0.38
▸ MTOR P42345 1/20 0.38
▸ EGFR P00533 3/20 0.38
▸ FGFR1 P11362 3/20 0.38
▸ KDR P35968 3/20 0.38
▸ NLRP3 Q96P20 1/20 0.38
▸ TSHR P16473 2/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ JAK1 P23458 2/20 0.35
▸ GAA P10253 1/20 0.35
▸ PKM P14618 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26651235 1.00 PIK3CG (0.38) PIK3CGPIK3CDPIK3CBMTOREGFR
SCHEMBL24309239 0.87 CCNT1 (0.40) PIK3CGPIK3CDPIK3CBMTOREGFR
SCHEMBL24309349 0.86 PIK3CG (0.42) PIK3CGPIK3CDPIK3CBMTOREGFR
SCHEMBL26806550 0.85 TSHR (0.39) PIK3CGPIK3CDPIK3CBMTORTSHR
SCHEMBL24310735 0.85 PIK3CD (0.39) PIK3CGPIK3CDPIK3CBMTOREGFR
SCHEMBL24309545 0.84 TSHR (0.40) PIK3CGPIK3CDPIK3CBMTOREGFR
SCHEMBL26806587 0.84 TSHR (0.40) PIK3CGPIK3CDPIK3CBMTOREGFR
SCHEMBL26806586 0.83 TSHR (0.42) PIK3CGPIK3CDPIK3CBMTOREGFR
SCHEMBL24310769 0.83 EGFR (0.44) PIK3CGPIK3CDPIK3CBMTOREGFR
SCHEMBL24310345 0.83 TSHR (0.43) PIK3CGPIK3CDPIK3CBMTOREGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback